title: Psychooncologic Aspects of Breast Cancer.
abstract: Around one third of all patients reveal signs of stress disorder and adaptation difficulties following breast cancer or during the course of the illness, often manifested clinically as fear and depression. Supportive treatment should be made available to all patients in the form of psycho-educative group sessions introducing information and assistance to help overcome the illness. The indication for extensive treatment, e.g. psychotherapy, can be deduced from the somatopsychic disorders presented. Individual or group therapy will be offered to the patient corresponding to her diagnostics and motivation. The aim of therapy should be discussed openly with the patient, that is, an improvement in the quality of life and the possibility to overcome the situation. In general, the various intervention programmes have proved to be beneficial for patients with cancer. These include relaxation therapy and stress management as well as behavioural therapy and supportive psychotherapy. Patients have high expectations of the therapy offered and this should be taken into careful consideration by all physicians, psychologists and others responsible for administering treatment. The aim of this work is mainly to present the clinical experience gained in a breast centre.
authors.affiliation: Psychosomatische Frauenheilkunde, Medizinische Hochschule Hannover, Germany.
authors.forename: Mechthild
authors.initials: M
authors.lastname: Neises
references.citation: Zentralbl Gynakol. 2001 Jan;123(1):27-36
references.pmid: 11385908
references.citation: Psychother Psychosom. 1998;67(2):94-104
references.pmid: 9556201
references.citation: Ann Oncol. 1999 Jun;10(6):627-36
references.pmid: 10442183
references.citation: Br J Cancer. 2000 Nov;83(10):1261-7
references.pmid: 11044347
references.citation: Aust N Z J Psychiatry. 2002 Apr;36(2):246-50
references.pmid: 11982548
references.citation: Psychother Psychosom Med Psychol. 1996 Aug;46(8):304-11
references.pmid: 8927686
references.citation: Psychother Psychosom Med Psychol. 1998 Sep-Oct;48(9-10):417-24
references.pmid: 9785972
references.citation: Psychooncology. 1995 Oct;4(3):197-202
references.pmid: 11655006
references.citation: Support Care Cancer. 2007 Jul;15(7):841-7
references.pmid: 17431690
references.citation: Psychother Psychosom Med Psychol. 2003 May;53(5):229-35
references.pmid: 12709891
references.citation: BMJ. 2005 Mar 26;330(7493):702
references.pmid: 15695497
references.citation: Obstet Gynecol. 2004 Jun;103(6):1211-7
references.pmid: 15172854
references.citation: Oncologist. 2000;5(4):302-11
references.pmid: 10964998
references.citation: J Psychosom Res. 2008 Apr;64(4):383-91
references.pmid: 18374737
references.citation: Br J Cancer. 2001 Jan;84(2):179-85
references.pmid: 11161373
references.citation: Ann Behav Med. 2006 Oct;32(2):98-103
references.pmid: 16972804
references.citation: Psychooncology. 2001 Nov-Dec;10(6):511-20
references.pmid: 11747063
references.citation: Psychooncology. 2001 Mar-Apr;10(2):103-13
references.pmid: 11268137